These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 7532275)

  • 1. Differential effects of phosphotyrosine phosphatase expression on hormone-dependent and independent pp60c-src activity.
    Way BA; Mooney RA
    Mol Cell Biochem; 1994 Oct; 139(2):167-75. PubMed ID: 7532275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of phosphatidylinositol-3-kinase by platelet-derived growth factor and insulin-like growth factor-1 is inhibited by a transmembrane phosphotyrosine phosphatase.
    Way BA; Mooney RA
    J Biol Chem; 1993 Dec; 268(35):26409-15. PubMed ID: 8253766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The catalytic subunit of phosphatidylinositol 3-kinase is a substrate for the activated platelet-derived growth factor receptor, but not for middle-T antigen-pp60c-src complexes.
    Roche S; Dhand R; Waterfield MD; Courtneidge SA
    Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):703-11. PubMed ID: 7519847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,25-dihydroxyvitamin D3 regulates pp60c-src activity and expression of a pp60c-src activating phosphatase.
    Chappel J; Ross FP; Abu-Amer Y; Shaw A; Teitelbaum SL
    J Cell Biochem; 1997 Dec; 67(4):432-8. PubMed ID: 9383703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The product of the protooncogene c-src is modified during the cellular response to platelet-derived growth factor.
    Ralston R; Bishop JM
    Proc Natl Acad Sci U S A; 1985 Dec; 82(23):7845-9. PubMed ID: 2415973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527.
    Cobb BS; Parsons JT
    Oncogene; 1993 Nov; 8(11):2897-903. PubMed ID: 7692368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a transmembrane phosphotyrosine phosphatase inhibits cellular response to platelet-derived growth factor and insulin-like growth factor-1.
    Mooney RA; Freund GG; Way BA; Bordwell KL
    J Biol Chem; 1992 Nov; 267(33):23443-6. PubMed ID: 1429686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of a cytoskeleton-associated, epidermal growth factor sensitive pp60c-src substrate.
    Maa MC; Wilson LK; Moyers JS; Vines RR; Parsons JT; Parsons SJ
    Oncogene; 1992 Dec; 7(12):2429-38. PubMed ID: 1281304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of growth factor receptor binding protein-2 by pp60c-src tyrosine kinase.
    Jones DA; Benjamin CW
    Arch Biochem Biophys; 1997 Jan; 337(2):143-8. PubMed ID: 9016807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Src and mitosis.
    Shalloway D; Bagrodia S; Chackalaparampil I; Shenoy S; Lin PH; Taylor SJ
    Ciba Found Symp; 1992; 170():248-65; discussion 265-75. PubMed ID: 1282857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restriction of the in vitro and in vivo tyrosine protein kinase activities of pp60c-src relative to pp60v-src.
    Coussens PM; Cooper JA; Hunter T; Shalloway D
    Mol Cell Biol; 1985 Oct; 5(10):2753-63. PubMed ID: 2426575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translocation of pp60c-src from the plasma membrane to the cytosol after stimulation by platelet-derived growth factor.
    Walker F; deBlaquiere J; Burgess AW
    J Biol Chem; 1993 Sep; 268(26):19552-8. PubMed ID: 7690037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cellular response to platelet-derived growth factor by low M(r) phosphotyrosine protein phosphatase overexpression.
    Berti A; Rigacci S; Raugei G; Degl'Innocenti D; Ramponi G
    FEBS Lett; 1994 Jul; 349(1):7-12. PubMed ID: 7519150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-derived growth factor induces phosphatidylinositol 3-kinase release from the middle T-pp60c-src complex and association with the platelet-derived growth factor receptor.
    Zhang QX; Baldwin GS
    Growth Factors; 1994; 10(1):41-51. PubMed ID: 7514012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin and thrombin receptor agonist peptide induce tyrosine phosphorylation and tyrosine kinases in the platelet cytoskeleton. Translocation of pp60c-src and integrin alpha IIb beta 3 (glycoprotein IIb/IIIa) is not required for aggregation, but is dependent on formation of large aggregate structures.
    Pumiglia KM; Feinstein MB
    Biochem J; 1993 Aug; 294 ( Pt 1)(Pt 1):253-60. PubMed ID: 7689831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress induces tyrosine phosphorylation of PDGF alpha-and beta-receptors and pp60c-src in mesangial cells.
    González-Rubio M; Voit S; Rodríguez-Puyol D; Weber M; Marx M
    Kidney Int; 1996 Jul; 50(1):164-73. PubMed ID: 8807585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell transformation and activation of pp60c-src by overexpression of a protein tyrosine phosphatase.
    Zheng XM; Wang Y; Pallen CJ
    Nature; 1992 Sep; 359(6393):336-9. PubMed ID: 1383828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low molecular weight protein-tyrosine phosphatase tyrosine phosphorylation by c-Src during platelet-derived growth factor-induced mitogenesis correlates with its subcellular targeting.
    Cirri P; Chiarugi P; Taddei L; Raugei G; Camici G; Manao G; Ramponi G
    J Biol Chem; 1998 Dec; 273(49):32522-7. PubMed ID: 9829986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sites of phosphorylation by protein kinase C and an intact SH2 domain are required for the enhanced response to beta-adrenergic agonists in cells overexpressing c-src.
    Moyers JS; Bouton AH; Parsons SJ
    Mol Cell Biol; 1993 Apr; 13(4):2391-400. PubMed ID: 7681147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Avian pp60c-src is more active when expressed in yeast than in vertebrate fibroblasts.
    Cooper JA; Runge K
    Oncogene Res; 1987; 1(4):297-310. PubMed ID: 2453017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.